Home › Blood Cancers
Blood Cancers clinical trials recruiting in the U.S.
157 studies for Blood Cancers are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX46 studies
- Boston, MA28 studies
- New York City, NY26 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA18 studies
- Durham, NC16 studies
- Chicago, IL16 studies
- Edison, NJ14 studies
- Columbus, OH14 studies
- Philadelphia, PA14 studies
- Nashville, TN13 studies
- Atlanta, GA13 studies
- Baldwin Park, CA13 studies
- Detroit, MI12 studies
- Milwaukee, WI12 studies
- Minneapolis, MN11 studies
- Dallas, TX11 studies
- Ann Arbor, MI11 studies
- Birmingham, AL11 studies
- Jacksonville, FL10 studies
- St. Louis, MO10 studies
- Omaha, NE10 studies
- Cincinnati, OH10 studies
- Cedar Rapids, IA9 studies
- Denver, CO9 studies
- Grand Rapids, MI9 studies
- Miami, FL9 studies
- Memphis, TN9 studies
- New Haven, CT8 studies
- Rochester, MN8 studies
- Aurora, CO8 studies
- Orange, CA8 studies
- Clifton, NJ8 studies
- Salt Lake City, UT8 studies
- San Francisco, CA8 studies
- San Antonio, TX8 studies
- Tampa, FL8 studies
- Oklahoma City, OK7 studies
By state
- Alabama11 studies
- Arizona13 studies
- Arkansas5 studies
- California36 studies
- Colorado14 studies
- Connecticut9 studies
- Delaware3 studies
- District of Columbia7 studies
- Florida28 studies
- Georgia16 studies
- Illinois17 studies
- Indiana8 studies
- Iowa9 studies
- Kansas8 studies
- Kentucky10 studies
- Louisiana6 studies
- Maryland29 studies
- Massachusetts28 studies
- Michigan23 studies
- Minnesota18 studies
- Missouri11 studies
- Nebraska10 studies
- Nevada4 studies
- New Hampshire3 studies
- New Jersey21 studies
- New York31 studies
- North Carolina24 studies
- North Dakota3 studies
- Ohio23 studies
- Oklahoma8 studies
- Oregon8 studies
- Pennsylvania21 studies
- Rhode Island4 studies
- South Carolina8 studies
- South Dakota5 studies
- Tennessee20 studies
- Texas49 studies
- Utah8 studies
- Virginia11 studies
- Washington20 studies
- West Virginia5 studies
- Wisconsin15 studies
Recently updated studies
CD70.CAR for AML and Other CD70+ Leukemias
RecruitingPhase 1
Up to age 75 · All sexes · Updated Nov 13, 2026 · NCT06345027Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT03486873Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06401356Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07007312The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
RecruitingObservational study
Ages 18 to 39 · All sexes · Updated Nov 10, 2026 · NCT04551378The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Nov 10, 2026 · NCT05436418Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 · All sexes · Updated Nov 9, 2026 · NCT06856226Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Nov 9, 2026 · NCT05470491Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Nov 9, 2026 · NCT05327023Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 85 · All sexes · Updated Nov 9, 2026 · NCT04959175HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06731504Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
All ages · All sexes · Updated Nov 4, 2026 · NCT04242095Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
RecruitingObservational study
Up to age 30 · All sexes · Updated Nov 4, 2026 · NCT06579469A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT04634552Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07809906Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Nov 2, 2026 · NCT06904066Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
RecruitingPhase 1/2Healthy volunteers welcome
Up to age 50 · All sexes · Updated Oct 30, 2026 · NCT05322850Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06960993Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Oct 29, 2026 · NCT05724121Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 29, 2026 · NCT06131801Prophylactic DLI-X for Leukemia Relapse After HCT
RecruitingPhase 1
Up to age 65 · All sexes · Updated Oct 29, 2026 · NCT07254793From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.